Medplus Health Services Limited — Others, 05-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

MedPlus Health Services Limited has shared a report from Axis Bank Limited, acting as the Monitoring Agency for the quarter ending December 31, 2024, regarding the utilization of funds from its Initial Public Offer (IPO). Key highlights include that there has been no deviation from the intended use of the IPO proceeds, which total ₹5,782.73 cr after expenses. The report confirms utilization is aligned with the original objectives, primarily funding working capital for its material subsidiary. This consistent monitoring reinforces investor confidence, suggesting a stable outlook for the company's financial health.